Hybridoma tumor cell lines and their monoclonal antibodies to th

Details Hybridoma tumor cell lines and their monoclonal antibodies to th Hybridoma tumor cell lines and their monoclonal antibodies to th

1985-10-31

1988-09-13

Nucker, Christine M.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 68, 4351722, 43524027, 435948, 436501, 436518, 436540, 436541, 436543, 436548, 436815, 530387, 530413, 530808, 530809, G01N 33577

Patent

active

047709936

ABSTRACT:
Disclosed are murine-derived hybridoma tumor cell lines and monoclonal anti-thaumatin antibody substances produced by these cell lines. The monoclonal antibody substances may be used alone or in combination in immunological procedures for isolation of thaumatin and for quantitative detection of thaumatin in fluid samples.

REFERENCES:
patent: 4376110 (1983-03-01), David et al.
Haugh et al., Nature, vol. 271, pp. 381-383, 1978.
Edwardson et al., Chemical Abstracts, vol. 88, No. 19, Abstract #132122t, 1978.
Kohler et al., Nature, vol. 256, pp. 495-497, 1975.
Iyengar et al., "The Complete Amino Acid Sequence of the Sweet Protein Thaumatin I", Eur. J. Biochem. 96, pp. 193-204, (1979).
Science News, vol. 127, p. 186, Mar. 23, 1985.

Affiliated with

Also associated with

Rating

Hybridoma tumor cell lines and their monoclonal antibodies to th does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybridoma tumor cell lines and their monoclonal antibodies to th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridoma tumor cell lines and their monoclonal antibodies to th will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-806692